Pharming Group N.V. (PHAR)

8.51

0.00 (0.00%)

At close: Apr 25, 2025, 3:12 PM

8.51

0.00%

After-hours: Apr 25, 2025, 04:05 PM EDT

Pharming Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	53.04M	61.74M	207.34M	191.72M	205.49M	74.27M	91.87M	70.37M	33.54M
Short-Term Investments	109.03M	151.68M	n/a	n/a	n/a	-661.91K	n/a	n/a	n/a
Long-Term Investments	4.23M	10.4M	9.73M	9.95M	7.13M	6.17M	2.29M	2.75M	n/a
Other Long-Term Assets	31.26M	1.62M	1.33M	-303.43K	510.43K	2.54M	1.38M	1.6M	1.97M
Receivables	53.17M	42.62M	19.58M	15.88M	19.25M	26.28M	18.3M	12.22M	11.97M
Inventory	53.79M	56.76M	42.33M	27.28M	21.19M	16.21M	19.81M	22M	18.87M
Other Current Assets	1.00	10.54M	213K	227K	995K	n/a	1.81M	1.29M	974K
Total Current Assets	269.03M	316.34M	277.5M	249.18M	263.63M	119.3M	132.05M	105.87M	65.41M
Property-Plant & Equipment	23.3M	33.47M	39.15M	33.13M	21.69M	16.28M	9.61M	9.88M	6.36M
Goodwill & Intangibles	58.92M	71.27M	75.12M	83.75M	94.23M	79.32M	59.98M	67.94M	59.61M
Total Long-Term Assets	117.85M	146.51M	148.3M	147.72M	155.48M	136.33M	113.39M	93.5M	67.93M
Total Assets	386.88M	462.85M	425.8M	396.9M	419.12M	255.63M	245.45M	199.38M	133.34M
Account Payables	64.3M	14.51M	6.08M	5.14M	13.47M	36.22M	7.6M	11.31M	5.94M
Deferred Revenue	n/a	n/a	-56.23K	-44.35K	34.25M	34.61M	915.12K	964.56K	991.75K
Short-Term Debt	4.1M	1.82M	1.77M	2.42K	2.04M	45.55M	40.31M	26.87M	26.14M
Other Current Liabilities	-101.26K	7.74M	1.61M	2.71M	25.18M	30.54M	46.32M	35.29M	20.98M
Total Current Liabilities	71.24M	77.97M	59.7M	46.72M	76.97M	114.13M	94.49M	70.22M	54.03M
Long-Term Debt	75.44M	136.6M	122.92M	122.13M	122.57M	n/a	42.63M	70.98M	42.48M
Other Long-Term Liabilities	2.00	n/a	8.7M	17.04M	27.37M	19.89M	36.74M	33.4M	2.44M
Total Long-Term Liabilities	101.47M	166.1M	161.46M	157.46M	158.42M	24.25M	80.32M	106.61M	50.42M
Total Liabilities	172.72M	244.07M	221.16M	204.19M	235.39M	138.38M	174.81M	176.82M	104.45M
Total Debt	108.42M	171.54M	166.69M	161.59M	162.22M	58.14M	83.42M	97.53M	70.88M
Common Stock	7.77M	6.95M	7.51M	7.27M	7.86M	7.07M	7.11M	6.95M	4.79M
Retained Earnings	-265.36M	-265.26M	-256.43M	-269.45M	-317.51M	-333.38M	-381.65M	-427.42M	-293.45M
Comprehensive Income	n/a	-1.86M	-8.74M	2.17M	5.34M	4.16M	1.88M	-1.13M	63.1K
Shareholders Equity	214.16M	218.78M	204.64M	192.72M	183.73M	117.26M	70.64M	22.56M	28.89M
Total Investments	113.12M	162.08M	9.73M	9.95M	7.13M	5.51M	2.29M	2.75M	n/a